Leukemia Research
Volume 33, Issue 2 , Pages 244-249, February 2009

Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantation

  • Z.Y. Lim

      Affiliations

    • Department of Haematological Medicine, Kings College Hospital, London, UK
    • On behalf of the British Society of Bone Marrow Transplantation.
    • ,
  • G. Cook

      Affiliations

    • Department of Haematology, St. James University Hospital, Leeds, UK
    • On behalf of the British Society of Bone Marrow Transplantation.
    • ,
  • P.R. Johnson

      Affiliations

    • Department of Haematology, Western General Hospital, Edinburgh, UK
    • On behalf of the British Society of Bone Marrow Transplantation.
    • ,
  • Anne Parker

      Affiliations

    • Department of Haematology, Glasgow Royal Infirmary, UK
    • On behalf of the British Society of Bone Marrow Transplantation.
    • ,
  • M. Zuckerman

      Affiliations

    • Department of Virology, Kings College Hospital, London, UK
    • On behalf of the British Society of Bone Marrow Transplantation.
    • ,
  • D. Marks

      Affiliations

    • Department of Haematology, Bristol Royal Infirmary, UK
    • On behalf of the British Society of Bone Marrow Transplantation.
    • ,
  • H. Wiltshire

      Affiliations

    • Roche Products Ltd., Welwyn Garden City, UK
    • On behalf of the British Society of Bone Marrow Transplantation.
    • ,
  • G.J. Mufti

      Affiliations

    • Department of Haematological Medicine, Kings College Hospital, London, UK
    • On behalf of the British Society of Bone Marrow Transplantation.
    • ,
  • A. Pagliuca

      Affiliations

    • Department of Haematological Medicine, Kings College Hospital, London, UK
    • On behalf of the British Society of Bone Marrow Transplantation.
    • Corresponding Author InformationCorresponding author. Tel.: +44 2032993709; fax: +44 2032993514.

Received 16 April 2008; received in revised form 7 July 2008; accepted 17 July 2008. published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(08)00344-5

doi:10.1016/j.leukres.2008.07.016

Leukemia Research
Volume 33, Issue 2 , Pages 244-249, February 2009

Article Tools

* Image Usage & Resolution